JNJ
NYSEUSJohnson & Johnson
Sector: Healthcare
About Johnson & Johnson
Johnson & Johnson is a multinational corporation that develops medical devices, pharmaceuticals, and consumer health products. Established in 1886, the company has built a strong reputation for quality and innovation, making it one of the largest and most diversified healthcare companies in the world. JNJ operates in three main segments: Pharmaceuticals, Medical Devices, and Consumer Health, with a robust pipeline of products and a global presence that enhances its market position. Recently, Johnson & Johnson has been focusing on expanding its pharmaceutical division, particularly in immunology and oncology. The company has also been navigating challenges related to litigation over its talc products while continuing to invest in research and development. As of early 2025, JNJ is poised to benefit from an aging population and increasing healthcare demands, which could drive future growth.
Key Metrics
Market Cap
approximately $400 billion
P/E Ratio
approximately 22
Dividend Yield
approximately 2.5%
Sector
Healthcare
Bull Case
- +Strong pipeline of innovative drugs expected to drive revenue growth.
- +Resilient consumer health segment providing stable cash flow.
- +Increasing global healthcare spending supporting market expansion.
Bear Case
- -Ongoing litigation risks could impact financial performance.
- -Competition from generic drugs and biosimilars may pressure margins.
- -Economic downturns could reduce consumer spending on health products.
Analyst Summary
Analysts generally view JNJ as a stable investment with moderate growth potential, though concerns about litigation and competition persist.
AI Analysis for JNJ
No analysis published yet for JNJ.
Subscribe to get notified when we cover this stock.
Frequently Asked Questions
Should you buy JNJ stock?
Whether JNJ is a good buy depends on your investment goals, risk tolerance, and current market conditions. Our AI evaluates Johnson & Johnson against sector peers using valuation metrics, catalyst analysis, and risk assessment. Subscribe to our newsletter for the latest AI-generated analysis.
Is Johnson & Johnson a good long-term investment?
Johnson & Johnson operates in the Healthcare sector on the NYSE. Long-term potential depends on industry trends, competitive positioning, and financial health. Our AI analysis provides data-driven insights with full reasoning — no black boxes.
What is Johnson & Johnson's stock price today?
BullOrBS does not provide real-time stock prices. For the latest JNJ price, check your brokerage or a financial data provider. Our focus is AI-driven fundamental analysis, not price tracking.
What sector is JNJ in?
Johnson & Johnson (JNJ) operates in the Healthcare sector and is listed on the NYSE.
Where is JNJ listed?
JNJ is listed on the NYSE. Johnson & Johnson is a US-listed company.
What does Johnson & Johnson do?
Johnson & Johnson is a US company in the Healthcare sector, trading under the ticker JNJ on the NYSE. For detailed AI analysis of their business and stock, see our latest coverage on this page.
What are alternatives to JNJ?
Sector peers in Healthcare include . Our AI elimination tournament compares these stocks head-to-head, scoring each on valuation, catalysts, risk, and momentum.
Get AI analysis of JNJ in your inbox
When our AI covers Johnson & Johnson, you'll be the first to know.
This page is AI-generated for educational purposes only. Not financial advice.BullOrBS is not affiliated with Johnson & Johnson or any financial institution. Always do your own research.